U.S. Capital Markets Stock News

NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Does Millicom’s Higher Sales, Lower Profit And New Dividend Shift The Bull Case For TIGO?

Millicom International Cellular recently reported second-quarter 2026 results showing higher sales of US$2,179 million but lower net income of US$109 million year-on-year, and its board declared a US$1.50 per share interim dividend to be paid in two US dollar installments in early 2027. This combination of stronger top-line performance, weaker earnings, and a maintained cash return via dividends highlights how Millicom is balancing growth investments with shareholder distributions. We’ll now...
NYSE:NVST
NYSE:NVSTMedical Equipment

How Investors May Respond To Envista Holdings (NVST) Earnings Rebound And Aggressive Share Buybacks

Envista Holdings reported past second-quarter 2026 results showing sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33 from US$0.16 a year earlier. Over the same period, Envista also completed US$267.05 million of share repurchases across two authorizations, reducing its share count by almost 8%, which amplifies the impact of its earnings rebound for remaining shareholders. We’ll now examine how Envista’s stronger...
NYSE:MMS
NYSE:MMSProfessional Services

Maximus (MMS) Flags Revenue Uncertainty, Is The Stock Still Undervalued?

Maximus (MMS) drew investor attention after its fiscal 2026 third quarter results and updated guidance pointed to revenue near the lower end of expectations, while management flagged ongoing uncertainty from contract delays and weaker award conversion. See our latest analysis for Maximus. The earnings update and softer revenue guidance have coincided with weaker share price momentum for Maximus, with the stock down 35.17% year to date on a share price basis and the 5 year total shareholder...
NYSE:DVA
NYSE:DVAHealthcare

DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong

DaVita stock has delivered a 78.0% return over the past three years, yet the latest valuation checks still suggest the shares lean cheap rather than fully priced in. Over three years DaVita has returned 78.0%, which puts more focus on whether the current valuation leaves enough room for further upside. Future cash generation from its dialysis network can support the current share price, but ongoing cost pressures and reimbursement uncertainty may limit how much investors are willing to pay...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

How Investors Are Reacting To Rhythm Pharmaceuticals (RYTM) UK Orphan Expansion For IMCIVREE In Hypothalamic Obesity

Rhythm Pharmaceuticals recently received expanded UK MHRA marketing authorization for IMCIVREE (setmelanotide) to treat obesity and control hunger in adults and children 4 years and older with acquired hypothalamic obesity due to hypothalamic injury or impairment, alongside orphan drug designation for this indication, based on supportive Phase 2 and Phase 3 TRANSCEND trial data. This expansion meaningfully broadens IMCIVREE’s eligible patient pool in the UK and underscores the clinical...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen (AMGN) Stock Looks Below Fair Value As Caution Lingers

Amgen stock has delivered a strong 116.3% return over the past 5 years, while the current checks show a mixed picture and the Discounted Cash Flow (DCF) intrinsic value estimate still points to meaningful upside compared with the market price. Over 5 years, Amgen has returned 116.3%, which puts more focus on whether the recent share price now already reflects much of the long term opportunity. The planned Science and Innovation Center in Hyderabad can support expectations for future research...
NYSE:IRM
NYSE:IRMSpecialized REITs

Is Iron Mountain (IRM) Fully Valued After Record Q2 Results And A Raised Outlook?

Iron Mountain (IRM) is back in focus after reporting record second quarter results, with revenue up 19% year over year and rapid expansion in its Data Center, ALM, and Digital businesses. See our latest analysis for Iron Mountain. The share price reaction has been strong, with Iron Mountain’s year to date share price return of 52.11% and five year total shareholder return of 235.99% pointing to building momentum as investors reassess growth prospects and risk. If Iron Mountain’s performance...
NYSE:BHVN
NYSE:BHVNBiotechs

Is Biohaven’s Narrowing Losses and AI Board Hire Altering The Investment Case For Biohaven (BHVN)?

Biohaven Ltd. reported second-quarter 2026 results showing a net loss of US$137.31 million and basic loss per share of US$0.91, both lower than a year earlier, and a six‑month net loss of US$267.84 million with loss per share of US$1.80. The company also added AI-focused investor and technologist John Yetimoglu to its Board, underscoring Biohaven’s push to integrate advanced computation across its research and development efforts. We’ll now examine how this progress in narrowing losses,...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Is Up 5.2% After Beating Q1 Earnings And Unveiling Fearless Planet Index – Has The Bull Case Changed?

In early August 2026, Gen Digital Inc. reported first-quarter sales of US$1,336 million and net income of US$215 million, affirmed a regular quarterly cash dividend of US$0.125 per share, and launched its Fearless Planet Index cyber threat intelligence hub. The Fearless Planet Index, which converts billions of real-world security signals into country-level scam and threat insights, underscores Gen Digital’s focus on data-driven cyber safety tools for individuals and small businesses. We’ll...
NYSE:KNF
NYSE:KNFBasic Materials

The Bull Case For Knife River (KNF) Could Change Following Raised 2026 Revenue Outlook Amid Lower Q2 Profit

In early August 2026, Knife River Corporation reported second-quarter 2026 results showing revenue of US$938.59 million versus US$833.76 million a year earlier, while net income declined to US$43.88 million from US$50.60 million, and simultaneously raised full-year 2026 revenue guidance to a range of US$3.40 billion to US$3.60 billion. Despite weaker quarterly earnings, the decision to lift full-year revenue guidance suggests management sees enough demand visibility to support stronger...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Adeia (ADEA) Shares Moved, So What Is Driving Attention Now?

Adeia (ADEA) drew fresh attention after reporting second quarter and first half 2026 results, reaffirming full year revenue and net income guidance and pairing the update with a new quarterly dividend declaration. See our latest analysis for Adeia. The latest earnings release, dividend declaration and progress on the buyback program have come alongside a share price of $28.69, with a year-to-date share price return of 63.2% and a 1-year total shareholder return of 94.24%. The 3-year total...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco Stock Leads These Retail Names Tied To Higher Social Security Checks

Retirees may see a 3.2% to 3.6% Social Security cost of living adjustment for 2027, and that potential boost in monthly checks puts fresh attention on companies tied to everyday spending. If more income ends up in grocery aisles and discount chains, some stocks could sit closer to the checkout than others. This article walks through three stocks our screener flags as especially exposed to that story. The stocks in this article are just a sample, and the full screen surfaced 25 more U.S...
NYSE:KEYS
NYSE:KEYSElectronic

Why Keysight Technologies (KEYS) Is Back In The Spotlight

Keysight Technologies (KEYS) is in focus after presenting at the OCP APAC Summit 2026 in Taipei, where Abhijit Lahiri outlined the company’s role in data center and AI infrastructure testing solutions. See our latest analysis for Keysight Technologies. The recent OCP APAC appearance and product launches come against a backdrop of strong momentum for Keysight Technologies, with a 71.28% year to date share price return and a 115.13% total shareholder return over the past year, although the 1...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Gold.com (GOLD) Rises Ahead Of Earnings, Is The Stock Still A Bargain?

Gold.com (GOLD) is in focus after a recent 2.85% share price gain, as investors respond to optimism ahead of its upcoming earnings report, which is expected to show year over year growth. See our latest analysis for Gold.com. At a latest share price of US$43.81, Gold.com has seen a 30 day share price return of 12.13% and a year to date share price return of 26.00%. Its 1 year total shareholder return of 91.61% and 5 year total shareholder return of 130.51% point to strong longer term momentum...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Atlanticus (ATLC) Is Down 13.2% After Q2 Earnings Beat And Faster Mercury Integration Progress – Has The Bull Case Changed?

Atlanticus Holdings Corporation recently reported second-quarter 2026 results showing net income of US$49.72 million and diluted EPS from continuing operations of US$2.50, and its Board approved a quarterly cash dividend of US$0.476563 per share for Series B Cumulative Perpetual Preferred stockholders, payable on or about September 15, 2026 to holders of record on September 1, 2026. Beyond the stronger earnings, management highlighted faster-than-planned progress on the Mercury integration...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

What Is Fox (FOXA) Gaining From Its New Streaming Ad Partnership?

Fox Corp. (NasdaqGS:FOXA) unit Tubi Media Group has entered a new partnership with Gracenote, part of Nielsen, to upgrade content discovery and advertising across its streaming platforms. The deal focuses on using Gracenote metadata to sharpen contextual content recommendations and viewer targeting on Tubi and FOX One. Tubi Media Group plans to roll out advanced programmatic CTV ad capabilities as part of the agreement, aimed at improving relevance for advertisers and viewers. Fox is far...
NasdaqCM:SWMR
NasdaqCM:SWMRAerospace & Defense

Swarmer (SWMR) Lands Oak Grove Partnership, Is 28% Below Fair Value?

Swarmer (SWMR) stock is in focus after the company announced a partnership with Oak Grove Technologies to integrate its autonomous software into Oak Grove’s Chimera unmanned aircraft for U.S. defense missions. See our latest analysis for Swarmer. Alongside this Oak Grove partnership, Swarmer has seen strong momentum, with an 8.4% 1 day share price return and a 45.04% 90 day share price return. The year to date share price return of 38.68% points to building interest over a longer stretch. If...
NYSE:CAG
NYSE:CAGFood

Will Marigold’s Halal Indian Line Reveal a New Global Strategy for Conagra Brands (CAG)?

Conagra Brands Canada has launched Marigold, a chef-inspired line of Indian-style frozen entrées and vegetarian cooking sauces, developed with Indian chefs and prepared in Canada, now rolling out to retailers nationwide after an initial limited release. The focus on halal-certified and vegetarian Indian dishes positions Conagra to tap into growing demand for convenient, globally inspired meals that meet diverse dietary preferences. Next, we’ll examine how Marigold’s halal-certified,...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Why Kaiser Aluminum (KALU) Is Up 6.9% After Stronger Demand and Bullish Quarterly Update – And What's Next

Earlier this week, Kaiser Aluminum reported a bullish quarterly update highlighting stronger customer demand, improving market conditions and strengthening business fundamentals across its key end markets. This combination of improving demand signals and the company’s standout industry ratings has reinforced Kaiser Aluminum’s position as a leader among aluminum producers. We’ll now examine how this strengthening customer demand backdrop could influence Kaiser Aluminum’s existing investment...
NasdaqGS:HTHT
NasdaqGS:HTHTHospitality

Is H World Group (NasdaqGS:HTHT) Trading Below Fair Value?

H World Group stock has delivered a 27.7% return over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the shares trading at a discount to underlying fundamentals. H World Group is up 27.7% over the last year, which still leaves the valuation screens suggesting the share price has not fully caught up with fundamentals. The key support for the current valuation can come from the company’s ability to turn revenue into...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Beat Expectations And Lifted Guidance, Is The Stock Still Cheap?

FormFactor (FORM) is back in focus after reporting Q2 results that beat expectations and issuing Q3 guidance above consensus, with a large peer’s production order also reinforcing investor interest in semiconductor testing demand. See our latest analysis for FormFactor. FormFactor’s recent Q2 beat, stronger Q3 guidance and a peer’s large production order have coincided with a 14.29% 7 day share price return and a very large 1 year total shareholder return that appears to reflect ongoing...
NYSE:RDN
NYSE:RDNDiversified Financial

Radian Group (RDN) Names Mike Weinbach Chief Executive Officer

Radian Group (NYSE:RDN) appointed Mike Weinbach as chief executive officer, effective immediately, completing its planned leadership transition. The CEO change follows Radian Group’s acquisition of specialty insurer Inigo Limited, aligning leadership with the company’s broader multi-line specialty insurance ambitions. The move positions Radian Group to pursue a more global profile as it integrates Inigo Limited into its expanding insurance platform. For readers looking to compare Radian...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Can Inter & Co (INTR) Turn Record Margins And User Engagement Into Durable Monetization Power?

Inter & Co, Inc. reported second-quarter 2026 results showing net income of R$421.11 million versus R$315.13 million a year earlier, with both basic and diluted earnings per share from continuing operations rising year over year. An interesting highlight was Inter & Co’s record 10.1% net interest margin alongside a client base surpassing 45 million and 22 million daily log-ins, supporting higher monetization without a comparable increase in costs. We will now examine how these strong...
NYSE:BDX
NYSE:BDXMedical Equipment

Why Is Becton Dickinson (BDX) Getting Fresh Attention Today?

Becton Dickinson (BDX) stock is back in focus after the company completed enrollment in its PREVENT clinical trial, a key step for Phasix Mesh in incisional hernia prevention and a future U.S. regulatory submission. See our latest analysis for Becton Dickinson. The PREVENT trial milestone lands at a time when Becton Dickinson’s share price has gained 20.79% over the past 30 days and 26.83% over 90 days, while the 1 year total shareholder return is 21.66%. This suggests recent momentum...